|  Help  |  About  |  Contact Us

Publication : Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against <i>Salmonella</i>.

First Author  Chen M Year  2020
Journal  Science Volume  369
Issue  6502 Pages  450-455
PubMed ID  32703879 Mgi Jnum  J:297588
Mgi Id  MGI:6449447 Doi  10.1126/science.aaz1333
Citation  Chen M, et al. (2020) Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella. Science 369(6502):450-455
abstractText  The guanosine triphosphatase (GTPase) Rab32 coordinates a cell-intrinsic host defense mechanism that restricts the replication of intravacuolar pathogens such as Salmonella Here, we show that this mechanism requires aconitate decarboxylase 1 (IRG1), which synthesizes itaconate, a metabolite with antimicrobial activity. We find that Rab32 interacts with IRG1 on Salmonella infection and facilitates the delivery of itaconate to the Salmonella-containing vacuole. Mice defective in IRG1 rescued the virulence defect of a S. enterica serovar Typhimurium mutant specifically defective in its ability to counter the Rab32 defense mechanism. These studies provide a link between a metabolite produced in the mitochondria after stimulation of innate immune receptors and a cell-autonomous defense mechanism that restricts the replication of an intracellular bacterial pathogen.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

10 Bio Entities

Trail: Publication

0 Expression